Kuros Biosciences to Present at Major Healthcare Conference
Kuros Biosciences (“Kuros”), a pioneer in innovative biologic technologies, is gearing up for a significant presentation at the Piper Sandler 37th Annual Healthcare Conference. This prestigious event will occur over three days, focusing on advancements and innovations in the healthcare sector.
About the Conference
The conference will take place at The Lotte New York Palace in New York City, offering a platform for leading companies in the healthcare industry. Participants eagerly anticipate insightful discussions about the latest developments in medical technologies and treatment solutions.
Kuros' Presentation Highlights
Kuros is set to showcase its impressive commercial momentum and clinical advancements surrounding its MagnetOs product line. This presentation will emphasize the company’s initiatives to expand its market reach and explore new indications. Furthermore, Kuros aims to provide a comprehensive look at its journey toward sustainable profitability, highlighting recent investments intended to bolster its operational infrastructure for ongoing growth.
Key Presentation Details
During the event, Chris Fair, the CEO of Kuros Biosciences, will deliver a presentation that promises to shed light on critical developments and strategic directions of the company. This presentation is scheduled for Wednesday, ensuring attendees gain valuable insights into Kuros’ operations.
Event Insights
The following details encapsulate the essence of the presentation:
- Event: Piper Sandler 37th Annual Healthcare Conference
- Presenter: Chris Fair, CEO, Kuros Biosciences
- Presentation Format: Company Presentation
- Date Scheduled: December 3, 2025
Company Overview
Kuros Biosciences is dedicated to discovering, developing, and delivering cutting-edge biologic technologies. Its flagship product, MagnetOs™, is an advanced bone graft solution renowned for its effectiveness. This innovative technology is already making waves in medical treatments across multiple continents.
About MagnetOs
MagnetOs has garnered significant attention due to its approach to enhancing bone growth. Clinical studies have shown remarkable outcomes, and it stands out as a reliable option for surgeons striving for better patient results. The product incorporates a unique technology designed to stimulate bone regeneration, offering an alternative to traditional graft methods.
Contact Information
For further inquiries about Kuros Biosciences or the conference presentation, the following contacts are available:
- Alexandre Müller - Investor Relations, Tel: +41 43 268 32 31, Email: IR@kurosbio.com
- Daniel Geiger - Chief Financial Officer, Tel: +41 44 733 47 41, Email: daniel.geiger@kurosbio.com
Frequently Asked Questions
What is the purpose of Kuros Biosciences' presentation?
The presentation will focus on the company's clinical advancements, market expansion, and path to profitability.
When and where is the Piper Sandler Healthcare Conference?
The conference is scheduled from December 2-4, 2025, at The Lotte New York Palace in New York City.
Who will be presenting on behalf of Kuros Biosciences?
Chris Fair, the CEO, will present, providing insights into the company’s strategies and products.
What is MagnetOs?
MagnetOs is an advanced bone graft technology designed to improve patient outcomes in bone fusion surgeries.
How can I contact Kuros Biosciences for more information?
You can contact Alexandre Müller or Daniel Geiger through the provided phone numbers or emails for any inquiries related to Kuros Biosciences.